Junín virus pathogenesis and virus replication

Viruses

Volumn 4, Issue 10, 2012, Pages 2317-2339

  Grant, Ashley ^a   Seregin, Alexey ^a   Huang, Cheng ^a   Kolokoltsova, Olga ^a   Brasier, Allan ^a   Peters, Clarence ^a   Paessler, Slobodan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Arenavirus; Jun n virus; Pathogenesis

Indexed keywords

ALPHA INTERFERON; ARENAVIRUS NEUTRALIZING ANTIBODY; ARENAVIRUS VACCINE; CD71 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; JUNIN VIRUS IMMUNE PLASMA; JUNIN VIRUS IMMUNOGLOBULIN F(AB')2 FRAGMENT; JUNIN VIRUS IMMUNOGLOBULIN G; JUNIN VIRUS IMMUNOGLOBULIN G1,2,3,4; JUNIN VIRUS IMMUNOGLOBULIN G1,2,4; JUNIN VIRUS VACCINE; JUNIN VIRUS VACCINE STRAIN XJ; JUNIN VIRUS VACCINE STRAIN XJ0; JUNIN VIRUS VACCINE STRAIN XJC13; LIVE ATTENUATED ALPHAVIRUS BASED VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY; RIBAVIRIN; TC83 VACCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ARENAVIRUS; ARGENTINE HEMORRHAGIC FEVER; ASYMPTOMATIC INFECTION; ATAXIA; BLEEDING; BOLIVIAN HEMORRHAGIC FEVER; CALLITRICHINAE; CD4 CD8 RATIO; CRANIAL NERVE PARALYSIS; CROSS PROTECTION; CROSS REACTION; DRUG APPROVAL; DRUG EFFICACY; DRUG ISOLATION; DRUG MEGADOSE; DRUG SYNTHESIS; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EBOLA VIRUS; FEVER; GAIT DISORDER; GUINEA PIG; HUMAN; HUMORAL IMMUNITY; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INNATE IMMUNITY; JUNIN VIRUS; MOLECULAR BIOLOGY; MULTIPLE DRUG DOSE; NATURAL HOST; NEUROLOGIC DISEASE; NONHUMAN; NYSTAGMUS; PATHOPHYSIOLOGY; PERSISTENT INFECTION; PREVALENCE; PROTEIN FUNCTION; REVIEW; SINGLE DRUG DOSE; TARGET CELL; THROMBOCYTOPENIA; TREMOR; UNSPECIFIED SIDE EFFECT; VACCINATION; VASCULAR ENDOTHELIUM; VIRAL CLEARANCE; VIREMIA; VIRUS ATTENUATION; VIRUS ENTRY; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODIES, VIRAL; ARENAVIRIDAE INFECTIONS; DISEASE MODELS, ANIMAL; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; IMMUNITY, INNATE; JUNIN VIRUS; MEMBRANE GLYCOPROTEINS; RODENTIA; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

ANIMALIA; ARENAVIRUS; JUNIN VIRUS; RODENTIA;

EID: 84868127075     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v4102317     Document Type: Review

References (125)

1. Mills, J.N.; Ellis, B.A.; Childs, J.E.; McKee, K.T. Jr.; Maiztegui, J.I.; Peters, C.J.; Ksiazek, T.G.; Jahrling, P.B. Prevalence of infection with junin virus in rodent populations in the epidemic area of argentine hemorrhagic fever. T. Am. J. Trop. Med. Hyg. 1994, 51, 554-562.
2. Parodi, A.S.; Coto, C.E.; Boxaca, M.; Lajmanovich, S.; Gonzalez, S. Characteristics of junin virus. Etiological agent of argentine hemorrhagic fever. Archiv fur die gesamte Virusforschung 1966, 19, 393-402.
3. Buchmeier MJ, d.l.T.J. Peters CJ, Arenaviridae: The viruses and their replication. In Fields virology, Knipe DM, H.P. Ed. Wolter Kluwer Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007; pp 1791-1827.
4. Tortorici, M.A.; Albarino, C.G.; Posik, D.M.; Ghiringhelli, P.D.; Lozano, M.E.; Rivera Pomar, R.; Romanowski, V. Arenavirus nucleocapsid protein displays a transcriptional antitermination activity in vivo. Vir. Res. 2001, 73, 41-55.
5. Meyer, B.J.; Southern, P.J. Sequence heterogeneity in the termini of lymphocytic choriomeningitis virus genomic and antigenomic rnas. J. Virol. 1994, 68, 7659-7664.
6. Beyer, W.R.; Popplau, D.; Garten, W.; von Laer, D.; Lenz, O. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase ski-1/s1p. J. Virol. 2003, 77, 2866-2872.
7. Lenz, O.; ter Meulen, J.; Klenk, H.D.; Seidah, N.G.; Garten, W. The lassa virus glycoprotein precursor gp-c is proteolytically processed by subtilase ski-1/s1p. P. Natl. Acad. Sci. USA 2001, 98, 12701-12705.
8. Pinschewer, D.D.; Perez, M.; Sanchez, A.B.; de la Torre, J.C. Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. P. Natl. Acad. Sci. USA 2003, 100, 7895-7900.
9. Poch, O.; Sauvaget, I.; Delarue, M.; Tordo, N. Identification of four conserved motifs among the rna-dependent polymerase encoding elements. EMBO J. 1989, 8, 3867-3874.
10. Perez, M.; Craven, R.C.; de la Torre, J.C. The small ring finger protein z drives arenavirus budding: Implications for antiviral strategies. P. Natl. Acad. Sci. USA 2003, 100, 12978-12983.
11. Strecker, T.; Eichler, R.; Meulen, J.; Weissenhorn, W.; Dieter Klenk, H.; Garten, W.; Lenz, O. Lassa virus z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J. Virol. 2003, 77, 10700-10705.
12. Urata, S.; Noda, T.; Kawaoka, Y.; Yokosawa, H.; Yasuda, J. Cellular factors required for lassa virus budding. J. Virol. 2006, 80, 4191-4195.
13. Briese, T.; Paweska, J.T.; McMullan, L.K.; Hutchison, S.K.; Street, C.; Palacios, G.; Khristova, M.L.; Weyer, J.; Swanepoel, R.; Egholm, M. et al. Genetic detection and characterization of lujo virus, a new hemorrhagic fever-associated arenavirus from southern africa. PLoS Pathog. 2009, 5, e1000455.
14. Enria, D.A.; Briggiler, A.M.; Pini, N.; Levis, S. Clinical manifestations of new world hantaviruses. Curr. Top. Microbiol. 2001, 256, 117-134.
15. Briggiler AM, L.S. Enria DA, Maiztegui JI, Argentine hemorrhagic fever in pregnant women. Medicina 1990, 50.
16. McKee, K.T. Jr.; Mahlandt, B.G.; Maiztegui, J.I.; Green, D.E.; Peters, C.J. Virus-specific factors in experimental argentine hemorrhagic fever in rhesus macaques. J. Med. Virol. 1987, 22, 99-111.
17. Gonzalez, P.H.; Cossio, P.M.; Arana, R.; Maiztegui, J.I.; Laguens, R.P. Lymphatic tissue in argentine hemorrhagic fever. Pathologic features. Arch. Patho. l Lab. Med. 1980, 104, 250-254.
18. Fennewald, S.M.; Aronson, J.F.; Zhang, L.; Herzog, N.K. Alterations in nf-kappab and rbp-jkappa by arenavirus infection of macrophages in vitro and in vivo. J. Virol. 2002, 76, 1154-1162.
19. Baize, S.; Kaplon, J.; Faure, C.; Pannetier, D.; Georges-Courbot, M.C.; Deubel, V. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 2004, 172, 2861-2869.
20. Mahanty, S.; Bausch, D.G.; Thomas, R.L.; Goba, A.; Bah, A.; Peters, C.J.; Rollin, P.E. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute lassa fever. J. Infect. Dis. 2001, 183, 1713-1721.
21. Peters, C.J.; Liu, C.T.; Anderson, G.W. Jr.; Morrill, J.C.; Jahrling, P.B. Pathogenesis of viral hemorrhagic fevers: Rift valley fever and lassa fever contrasted. Rev Infect Dis 1989, 11 Suppl 4, S743-749.
22. Lukashevich, I.S.; Maryankova, R.; Vladyko, A.S.; Nashkevich, N.; Koleda, S.; Djavani, M.; Horejsh, D.; Voitenok, N.N.; Salvato, M.S. Lassa and mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on il-8 and tnf-alpha gene expression. J. Med. Virol. 1999, 59, 552-560.
23. Rambukkana, A.; Kunz, S.; Min, J.; Campbell, K.P.; Oldstone, M.B. Targeting schwann cells by nonlytic arenaviral infection selectively inhibits myelination. Proc. Natl. Acad. Sci. USA 2003, 100, 16071-16076.
24. Enria, D.A.; Briggiler, A.M.; Fernandez, N.J.; Levis, S.C.; Maiztegui, J.I. Importance of dose of neutralising antibodies in treatment of argentine haemorrhagic fever with immune plasma. Lancet 1984, 2, 255-256.
25. Peters CJ, L.C. Anderson GW, Morrill JC Jr, Jahrling PB. Pathogenesis of viral hemorrhagic fevers. Rev. Infect Dis. 1989, 11, S749-S749.
26. Kolokoltsova, O.A.; Yun, N.E.; Poussard, A.L.; Smith, J.K.; Smith, J.N.; Salazar, M.; Walker, A.; Tseng, C.T.; Aronson, J.F.; Paessler, S. Mice lacking alpha/beta and gamma interferon receptors are susceptible to junin virus infection. J. Virol. 84, 13063-13067.
27. Giovanniello, O.A.; Nejamkis, M.R.; Galassi, N.V.; Nota, N.R. Immunosuppression in experimental junin virus infection of mice. Intervirol. 1980, 13, 122-125.
28. Gomez, R.M.; Jaquenod de Giusti, C.; Sanchez Vallduvi, M.M.; Frik, J.; Ferrer, M.F.; Schattner, M. Junin virus. A xxi century update. Microbes and infection / Institut Pasteur 2011, 13, 303-311.
29. Weissenbacher, M.C.; de Guerrero, L.B.; Boxaca, M.C. Experimental biology and pathogenesis of junin virus infection in animals and man. B. World Health Organ. 1975, 52, 507-515.
30. Campetella, O.E.; Galassi, N.V.; Sanjuan, N.; Barrios, H.A. Susceptible adult murine model for junin virus. J. Med. Virol. 1988, 26, 443-451.
31. Campetella, O.E.; Barrios, H.A.; Galassi, N.V. Junin virus-induced delayed-type hypersensitivity suppression in adult mice. J. Med. Virol. 1988, 25, 227-235.
32. Weissenbacher, M.C.; Calello, M.A.; Quintans, C.J.; Panisse, H.; Woyskowsky, N.M.; Zannoli, V.H. Junin virus infection in genetically athymic mice. Intervirol. 1983, 19, 1-5.
33. Weissenbacher, M.C.; Schmunis, G.A.; Parodi, A.S. Junin virus multiplication in thymectomized mice. Effect of thymus and immunocompetent cells grafting. Arch. Gesamte Virusforsch. 1969, 26, 63-73.
34. Budzko, D.B.; Casals, J.; Waksman, B.H. Enhanced resistance against junin virus infection induced by corynebacterium parvum. Infect. Immun. 1978, 19, 893-897.
35. Nejamkis, M.R.; Nota, N.R.; Weissenbacher, M.C.; Guerrero, L.B.; Giovanniello, O.A. Passive immunity against junin virus in mice. Acta Virol. 1975, 19, 237-244.
36. Nota, N.R.; Nejamkis, M.R.; Giovanniello, O.A. Further experiments on the action of antithymocyte serum in experimental junin virus infection. Acta Virol. 1976, 20, 61-65.
37. Rabinovich, R.D.; Calello, M.A.; Boxaca, M.C.; Quintans, C.J.; Weissenbacher, M.C. Mouse splenocyte transfer effect depends on donor's junin virus infection stage. Intervirol. 1988, 29, 21-26.
38. Campetella, O.E.; Galassi, N.V.; Barrios, H.A. Contrasuppressor cells induced by junin virus. Immunology 1990, 69, 629-631.
39. Kenyon, R.H.; Green, D.E.; Peters, C.J. Effect of immunosuppression on experimental argentine hemorrhagic fever in guinea pigs. J. Virol. 1985, 53, 75-80.
40. Carballal, G.; Cossio, P.M.; Laguens, R.P.; Ponzinibbio, C.; Oubina, J.R.; Meckert, P.C.; Rabinovich, A.; Arana, R.M. Junin virus infection of guinea pigs: Immunohistochemical and ultrastructural studies of hemopoietic tissue. J. Infect. Dis. 1981, 143, 7-14.
41. Elsner, B.; Boxaca, M.C.; Weissenbacher, M.; De Guerrero, L.B. [experimental junin virus infection of guinea pigs. I. Pathological anatomy]. Medicina (B Aires) 1976, 36, 197-206.
42. Maiztegui, J.I.; Laguens, R.P.; Cossio, P.M.; Casanova, M.B.; de la Vega, M.T.; Ritacco, V.; Segal, A.; Fernandez, N.J.; Arana, R.M. Ultrastructural and immunohistochemical studies in five cases of argentine hemorrhagic fever. J. Infect. Dis. 1975, 132, 35-53.
43. Kenyon, R.H.; Green, D.E.; Maiztegui, J.I.; Peters, C.J. Viral strain dependent differences in experimental argentine hemorrhagic fever (junin virus) infection of guinea pigs. Intervirol. 1988, 29, 133-143.
44. Yun, N.E.; Linde, N.S.; Dziuba, N.; Zacks, M.A.; Smith, J.N.; Smith, J.K.; Aronson, J.F.; Chumakova, O.V.; Lander, H.M.; Peters, C.J. et al. Pathogenesis of xj and romero strains of junin virus in two strains of guinea pigs. Am. J. Trop. Med. Hyg. 2008, 79, 275-282.
45. Oubina, J.R.; Carballal, G. Neurotropism of a high-passage xj strain of junin virus. J. Med. Virol. 1985, 15, 157-161.
46. Laguens, R.M.; Avila, M.M.; Samoilovich, S.R.; Weissenbacher, M.C.; Laguens, R.P. Pathogenicity of an attenuated strain (xjcl3) of junin virus. Morphological and virological studies in experimentally infected guinea pigs. Intervirol. 1983, 20, 195-201.
47. Sabattini, M.S.; Maiztegui, J.I. [argentine hemorrhagic fever]. Medicina (B Aires) 1970, 30, Suppl 1:111-128.
48. Vitullo, A.D.; Hodara, V.L.; Merani, M.S. Effect of persistent infection with junin virus on growth and reproduction of its natural reservoir, calomys musculinus. Am. J. Trop. Med. Hyg. 1987, 37, 663-669.
49. Lampuri, J.S.; Vidal, M.D.; Coto, C.E. [response of calomys musculinus to experimental infection with junin virus]. Medicina 1982, 42, 61-66.
50. Sabattini, M.S.; Gonzalez, L.E.; de Rios Diaz, G.; Vega, V.R. Infeccion natural y experimental de roedores con virus junin. Medicina (B Aires) 1977, 37, 149-161.
51. Chiappero, M.B.; Gardenal, C.N. Restricted gene flow in calomys musculinus (rodentia, muridae), the natural reservoir of junin virus. J. Hered. 2003, 94, 490-495.
52. Weissenbacher, M.C.; Calello, M.A.; Colillas, O.J.; Rondinone, S.N.; Frigerio, M.J. Argentine hemorrhagic fever: A primate model. Intervirol. 1979, 11, 363-365.
53. Weissenbacher, M.C.; Avila, M.M.; Calello, M.A.; Merani, M.S.; McCormick, J.B.; Rodriguez, M. Effect of ribavirin and immune serum on junin virus-infected primates. Med. Microbiol. Immunol. 1986, 175, 183-186.
54. Weissenbacher, M.C.; Coto, C.E.; Calello, M.A.; Rondinone, S.N.; Damonte, E.B.; Frigerio, M.J. Cross-protection in nonhuman primates against argentine hemorrhagic fever. Infect. Immun. 1982, 35, 425-430.
55. Samoilovich, S.R.; Calello, M.A.; Laguens, R.P.; Weissenbacher, M.C. Long-term protection against argentine hemorrhagic fever in tacaribe virus infected marmosets: Virologic and histopathologic findings. J. Med. Virol. 1988, 24, 229-236.
56. Samoilovich, S.R.; Pecci Saavedra, J.; Frigerio, M.J.; Weissenbacher, M.C. Nasal and intrathalamic inoculations of primates with tacaribe virus: Protection against argentine hemorrhagic fever and absence of neurovirulence. Acta Virol. 1984, 28, 277-281.
57. McKee, K.T. Jr.; Oro, J.G.; Kuehne, A.I.; Spisso, J.A.; Mahlandt, B.G. Safety and immunogenicity of a live-attenuated junin (argentine hemorrhagic fever) vaccine in rhesus macaques. Am. J. Trop. Med. Hyg. 1993, 48, 403-411.
58. McKee, K.T. Jr.; Oro, J.G.; Kuehne, A.I.; Spisso, J.A.; Mahlandt, B.G. Candid no. 1 argentine hemorrhagic fever vaccine protects against lethal junin virus challenge in rhesus macaques. Intervirol. 1992, 34, 154-163.
59. Jahrling PB, H.R. Eddy GA, Johnson KM, Callis RT, Stephen EL. Lassa virus infection of rhesus monkeys. J. Infect. Dis. 1980, 141, 580-589.
60. Vallejos, D.A.; Ambrosio, A.M.; Feuillade, M.R.; Maiztegui, J.I. Lymphocyte subsets alteration in patients with argentine hemorrhagic fever. J. Med. Virol. 1989, 27, 160-163.
61. Ambrosio, A.M.; Gamboa, G.S.; Feuillade, M.R.; Briggiler, A.M.; Rimoldi, M.T. Peripheral blood leukocytes of patients with argentine hemorrhagic fever as effectors of antibody-dependent cell-cytotoxicity. J. Med. Virol. 1992, 37, 232-236.
62. Emonet, S.F.; Seregin, A.V.; Yun, N.E.; Poussard, A.L.; Walker, A.G.; de la Torre, J.C.; Paessler, S. Rescue from cloned cdnas and in vivo characterization of recombinant pathogenic romero and live-attenuated candid #1 strains of junin virus, the causative agent of argentine hemorrhagic fever disease. J. Virol. 2011, 85, 1473-1483.
63. Avila, M.M.; Samoilovich, S.R.; Laguens, R.P.; Merani, M.S.; Weissenbacher, M.C. Protection of junin virus-infected marmosets by passive administration of immune serum: Association with late neurologic signs. J. Med. Virol. 1987, 21, 67-74.
64. Enria, D.A.; Briggiler, A.M.; Sanchez, Z. Treatment of argentine hemorrhagic fever. Antivir. Res. 2008, 78, 132-139.
65. Kunz, S. The role of the vascular endothelium in arenavirus haemorrhagic fevers. Thromb. Haemostasis. 2009, 102, 1024-1029.
66. Yang, Z.Y.; Duckers, H.J.; Sullivan, N.J.; Sanchez, A.; Nabel, E.G.; Nabel, G.J. Identification of the ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 2000, 6, 886-889.
67. Andrews, B.S.; Theofilopoulos, A.N.; Peters, C.J.; Loskutoff, D.J.; Brandt, W.E.; Dixon, F.J. Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect. Immun. 1978, 20, 776-781.
68. Gomez, R.M.; Pozner, R.G.; Lazzari, M.A.; D'Atri, L.P.; Negrotto, S.; Chudzinski-Tavassi, A.M.; Berria, M.I.; Schattner, M. Endothelial cell function alteration after junin virus infection. Thromb. Haemostasis. 2003, 90, 326-333.
69. Elsner, B.; Schwarz, E.; Mando, O.G.; Maiztegui, J.; Vilches, A. Pathology of 12 fatal cases of argentine hemorrhagic fever. T. Am. J. Trop. Med. Hyg. 1973, 22, 229-236.
70. Radoshitzky, S.R.; Abraham, J.; Spiropoulou, C.F.; Kuhn, J.H.; Nguyen, D.; Li, W.; Nagel, J.; Schmidt, P.J.; Nunberg, J.H.; Andrews, N.C. et al. Transferrin receptor 1 is a cellular receptor for new world haemorrhagic fever arenaviruses. Nature 2007, 446, 92-96.
71. Radoshitzky, S.R.; Kuhn, J.H.; Spiropoulou, C.F.; Albarino, C.G.; Nguyen, D.P.; Salazar-Bravo, J.; Dorfman, T.; Lee, A.S.; Wang, E.; Ross, S.R. et al. Receptor determinants of zoonotic transmission of new world hemorrhagic fever arenaviruses. P. Natl. Acad. Sci. USA 2008, 105, 2664-2669.
72. Abraham, J.; Corbett, K.D.; Farzan, M.; Choe, H.; Harrison, S.C. Structural basis for receptor recognition by new world hemorrhagic fever arenaviruses. Nat. Ctruct. Mol. Biol. 2010, 17, 438-444.
73. Cuevas, C.D.; Lavanya, M.; Wang, E.; Ross, S.R. Junin virus infects mouse cells and induces innate immune responses. J. Virol. 2011, 85, 11058-11068.
74. Droniou-Bonzom, M.E.; Reignier, T.; Oldenburg, J.E.; Cox, A.U.; Exline, C.M.; Rathbun, J.Y.; Cannon, P.M. Substitutions in the glycoprotein (gp) of the candid#1 vaccine strain of junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of gp. J. Virol. 2011, 85, 13457-13462.
75. Albarino, C.G.; Bird, B.H.; Chakrabarti, A.K.; Dodd, K.A.; Flint, M.; Bergeron, E.; White, D.M.; Nichol, S.T. The major determinant of attenuation in mice of the candid1 vaccine for argentine hemorrhagic fever is located in the g2 glycoprotein transmembrane domain. J. Virol. 2011, 85, 10404-10408.
76. Ambrosio, A.M.; Enria, D.A.; Maiztegui, J.I. Junin virus isolation from lympho-mononuclear cells of patients with argentine hemorrhagic fever. Intervirol. 1986, 25, 97-102.
77. Ambrosio, M.; Vallejos, A.; Saavedra, C.; Maiztegui, J.I. Junin virus replication in peripheral blood mononuclear cells of patients with argentine haemorrhagic fever. Acta Virol. 1990, 34, 58-63.
78. Laguens, M.; Chambo, J.G.; Laguens, R.P. In vivo replication of pathogenic and attenuated strains of junin virus in different cell populations of lymphatic tissue. Infect. Immun. 1983, 41, 1279-1283.
79. Laguens, R.M.; Chambo, J.G.; Laguens, R.P. Splenic dendritic cells and junin virus. Med. Microbiol. Immun. 1986, 175, 187-189.
80. Medeot, S.I.; Contigiani, M.S.; Sabattini, M.S.; Camara, A. The role of mononuclear blood cells in experimental junin virus spread to the central nervous system. Vir. Immun. y 1995, 8, 101-108.
81. Alche, L.E.; Coulombie, F.C.; Coto, C.E. [isolation of junin virus from blood and peripheral lymphocytes of infected calomys musculinus]. Rev. Argent. Microbiol. 1985, 17, 177-181.
82. Groseth, A.; Hoenen, T.; Weber, M.; Wolff, S.; Herwig, A.; Kaufmann, A.; Becker, S. Tacaribe virus but not junin virus infection induces cytokine release from primary human monocytes and macrophages. PLoS Neglect. Trop. Dis. 2011, 5, e1137.
83. Blejer, J.L.; Remesar, M.C.; Mosca, E.E.; Nejamkis, M.R. [role of macrophages in the dissemination of the junin virus in the rat]. Rev. Argent. Microbiol. 1985, 17, 229-232.
84. Coulombie, F.C.; Alche, L.E.; Lampuri, J.S.; Coto, C.E. Role of calomys musculinus peritoneal macrophages in age-related resistance to junin virus infection. J. Med. Virol. 1986, 18, 289-298.
85. Blejer, J.L.; Remesar, M.C.; Lerman, G.D.; Nejamkis, M.R. Macrophage maturity and modulation of response to junin virus in infected rats. J. Infect. Dis. 1986, 154, 478-482.
86. Levis, S.C.; Saavedra, M.C.; Ceccoli, C.; Feuillade, M.R.; Enria, D.A.; Maiztegui, J.I.; Falcoff, R. Correlation between endogenous interferon and the clinical evolution of patients with argentine hemorrhagic fever. J. Interfer. Res. 1985, 5, 383-389.
87. Levis, S.C.; Saavedra, M.C.; Ceccoli, C.; Falcoff, E.; Feuillade, M.R.; Enria, D.A.; Maiztegui, J.I.; Falcoff, R. Endogenous interferon in argentine hemorrhagic fever. J. Infect. Dis. 1984, 149, 428-433.
88. Lerer, G.D.; Saavedra, M.C.; Falcoff, R.; Maiztegui, J.I.; Molinas, F.C. Activity of a platelet protein kinase that phosphorylates fibrinogen and histone in argentine hemorrhagic fever. Acta Physiol. Pharm. L. 1991, 41, 377-386.
89. Pozner, R.G.; Ure, A.E.; Jaquenod de Giusti, C.; D'Atri, L.P.; Italiano, J.E.; Torres, O.; Romanowski, V.; Schattner, M.; Gomez, R.M. Junin virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type i ifn signaling. PLoS Pathog. 2010, 6, e1000847.
90. Dejean, C.B.; Ayerra, B.L.; Teyssie, A.R. Interferon response in the guinea pig infected with junin virus. J. Med. Virol. 1987, 23, 83-91.
91. Kenyon, R.H.; McKee, K.T. Jr.; Zack, P.M.; Rippy, M.K.; Vogel, A.P.; York, C.; Meegan, J.; Crabbs, C.; Peters, C.J. Aerosol infection of rhesus macaques with junin virus. Intervirol. 1992, 33, 23-31.
92. Marta, R.F.; Montero, V.S.; Hack, C.E.; Sturk, A.; Maiztegui, J.I.; Molinas, F.C. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in argentine hemorrhagic fever. T. Am. J. Trop. Med. Hyg. 1999, 60, 85-89.
93. Pythoud, C.; Rodrigo, W.W.; Pasqual, G.; Rothenberger, S.; Martinez-Sobrido, L.; de la Torre, J.C.; Kunz, S. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase ikk{varepsilon}. J. Virol. 2012.
94. Rodrigo, W.W.; Ortiz-Riano, E.; Pythoud, C.; Kunz, S.; de la Torre, J.C.; Martinez-Sobrido, L. Arenavirus nucleoproteins prevent activation of nuclear factor kappa b. J. Virol. 2012.
95. Ortiz-Riano, E.; Cheng, B.Y.; de la Torre, J.C.; Martinez-Sobrido, L. The c-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in np-z interaction and counteraction of the type i interferon response. J. Virol. 2011, 85, 13038-13048.
96. Martinez-Sobrido, L.; Giannakas, P.; Cubitt, B.; Garcia-Sastre, A.; de la Torre, J.C. Differential inhibition of type i interferon induction by arenavirus nucleoproteins. J. Virol. 2007, 81, 12696-12703.
97. Zhou, S.; Cerny, A.M.; Zacharia, A.; Fitzgerald, K.A.; Kurt-Jones, E.A.; Finberg, R.W. Induction and inhibition of type i interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 2010, 84, 9452-9462.
98. Fan, L.; Briese, T.; Lipkin, W.I. Z proteins of new world arenaviruses bind rig-i and interfere with type i interferon induction. J. Virol. 2010, 84, 1785-1791.
99. Huang, C.; Kolokoltsova, O.A.; Yun, N.E.; Seregin, A.V.; Poussard, A.L.; Walker, A.G.; Brasier, A.R.; Zhao, Y.; Tian, B.; de la Torre, J.C. et al. Junin virus infection activates the type i interferon pathway in a rig-i-dependent manner. PLoS Neglect. Trop. Dis. 2012, 6, e1659.
100. de Holstein, B.A.; Knecher, M.; Teyssie, A.R. [in vitro interferon induction by junin virus; effect of pre-treatment with the inhibitor]. REv. Asoc. Argent. Microbiol. 1977, 9, 22-27.
101. Remesar, M.C.; Blejer, J.L.; Lerman, G.D.; Dejean, C.; Nejamkis, M.R. [protection against encephalitis in rats caused by a pathogenic strain of the junin virus, using peripheral inoculation of an attenuated strain]. Rev. Argent. Microbiol. 1989, 21, 120-126.
102. Kolokoltsova, O.A.; Yun, N.E.; Poussard, A.L.; Smith, J.K.; Smith, J.N.; Salazar, M.; Walker, A.; Tseng, C.T.; Aronson, J.F.; Paessler, S. Mice lacking alpha/beta and gamma interferon receptors are susceptible to junin virus infection. J. Virol. 2010, 84, 13063-13067.
103. Weissenbacher, M.C.; Coto, C.E.; Calello, M.A. Cross-protection between tacaribe complex viruses. Presence of neutralizing antibodies against junin virus (argentine hemorrhagic fever) in guinea pigs infected with tacaribe virus. Intervirol. 1975, 6, 42-49.
104. Carballal, G.; Calello, M.A.; Laguens, R.P.; Weissenbacher, M.C. Tacaribe virus: A new alternative for argentine hemorrhagic fever vaccine. J. Med. Virol. 1987, 23, 257-263.
105. Parodi, A.S. Greenway, D.J. Rugiero, H.R. Rivero, E. Frigerio, M.J. Mettler, W.E. Garzon, F. Boxaca, M. Guerrero, L.B. and Nota, N.R. Sobre la etiologia del bute epidemico de junin. Dia Medico 1958, 30, 2300-2302.
106. Candurra, N.A.; Damonte, E.B.; Coto, C.E. Antigenic relationships between attenuated and pathogenic strains of junin virus. J. Med. Virol. 1989, 27, 145-150.
107. Ruggiero, H.A.; Perez Isquierdo, F.; Milani, H.A.; Barri, A.; Val, A.; Maglio, F.; Astarloa, L.; Gonzalez Cambaceres, C.; Milani, H.L.; Tallone, J.C. [treatment of argentine hemorrhagic fever with convalescent's plasma. 4433 cases]. Presse Med 1986, 15, 2239-2242.
108. de Guerrero, L.B.; Boxaca, M.C.; Malumbres, E.; Dejean, C.; Caruso, E. Early protection to junin virus of guinea pig with an attenuated junin virus strain. Acta Virol. 1985, 29, 334-337.
109. Ambrosio, A.; Saavedra, M.; Mariani, M.; Gamboa, G.; Maiza, A. Argentine hemorrhagic fever vaccines. Hum. Vaccines 2011, 7, 694-700.
110. Albarino, C.G.; Ghiringhelli, P.D.; Posik, D.M.; Lozano, M.E.; Ambrosio, A.M.; Sanchez, A.; Romanowski, V. Molecular characterization of attenuated junin virus strains. J. Gen. Virol. 1997, 78 (Pt 7), 1605-1610.
111. Medeot, S.I.; Contigiani, M.S.; Brandan, E.R.; Sabattini, M.S. Neurovirulence of wild and laboratory junin virus strains in animal hosts. J. Med. Virol. 1990, 32, 171-182.
112. Maiztegui, J.I.; McKee, K.T. Jr.; Barrera Oro, J.G.; Harrison, L.H.; Gibbs, P.H.; Feuillade, M.R.; Enria, D.A.; Briggiler, A.M.; Levis, S.C.; Ambrosio, A.M. et al. Protective efficacy of a live attenuated vaccine against argentine hemorrhagic fever. Ahf study group. J. Infect. Dis. 1998, 177, 277-283.
113. Cresta, B.; Padula, P.; de Martinez Segovia, M. Biological properties of junin virus proteins. I. Identification of the immunogenic glycoprotein. Intervirol. 1980, 13, 284-288.
114. Videla, C.; Carballal, G.; Remorini, P.; La Torre, J. Formalin inactivated junin virus: Immunogenicity and protection assays. J. Med. Virol. 1989, 29, 215-220.
115. Seregin, A.V.; Yun, N.E.; Poussard, A.L.; Peng, B.H.; Smith, J.K.; Smith, J.N.; Salazar, M.; Paessler, S. Tc83 replicon vectored vaccine provides protection against junin virus in guinea pigs. Vaccine 2010, 28, 4713-4718.
116. Maiztegui, J.I.; Fernandez, N.J.; de Damilano, A.J. Efficacy of immune plasma in treatment of argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 1979, 2, 1216-1217.
117. Kenyon, R.H.; Condie, R.M.; Jahrling, P.B.; Peters, C.J. Protection of guinea pigs against experimental argentine hemorrhagic fever by purified human igg: Importance of elimination of infected cells. Microbiol. Pathogen. 1990, 9, 219-226.
118. Parker, W.B. Metabolism and antiviral activity of ribavirin. Vir. Res. 2005, 107, 165-171.
119. Stephen, E.L. Jones, D.E. Peters, C.J. Eddy, G.A. Loizeaux, P.S. Jahrling, P.B. Ribavirin, a broad spectrum antiviral agent. In Ribavirin treatment of toga-, areana-and bunyavirus infections in subhuman primates and other laboratory animals species. Academic Press: New York, NY, USA, 1980.
120. McKee, K.T. Jr.; Huggins, J.W.; Trahan, C.J.; Mahlandt, B.G. Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever. Antimicrob. Agents Ch. 1988, 32, 1304-1309.
121. Barry, M.; Russi, M.; Armstrong, L.; Geller, D.; Tesh, R.; Dembry, L.; Gonzalez, J.P.; Khan, A.S.; Peters, C.J. Brief report: Treatment of a laboratory-acquired sabia virus infection. New Engl. J. Med. 1995, 333, 294-296.
122. Kilgore, P.E.; Ksiazek, T.G.; Rollin, P.E.; Mills, J.N.; Villagra, M.R.; Montenegro, M.J.; Costales, M.A.; Paredes, L.C.; Peters, C.J. Treatment of bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 1997, 24, 718-722.
123. Weissenbacher, M.C. Laguens, R.P. Coto, C.E. Argentine hemorrhagic fever. Curr. Top. Microbiol. 1987, 134, 79-116.
124. Kenyon, R.H.; Canonico, P.G.; Green, D.E.; Peters, C.J. Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (junin virus) in guinea pigs. Antimicrob. Agents Ch. 1986, 29, 521-523.
125. Salazar, M.; Yun, N.E.; Poussard, A.L.; Smith, J.N.; Smith, J.K.; Kolokoltsova, O.A.; Patterson, M.J.; Linde, J.; Paessler, S. Effect of ribavirin on junin virus infection in guinea pigs. Zoonoses Public Hlth. 2012, 59, 278-285.